MedPath

Efficacy of vildagliptin monotherapy on glycemic control in type 2 diabetic patients on hemodialysis.

Not Applicable
Completed
Conditions
Type 2 diabetic patients on hemodialysis
Registration Number
JPRN-UMIN000003661
Lead Sponsor
Hiroshi Maegawa
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1) Type 1 diabetic patients 2) Type 2 diabetic patients with insulin theapy 3) Patients with liver disease 4) Patients with cancer disease 5) Patients with inflammatory disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath